Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 4, 1999, Pages 921-929

  Pickett, Barby ^a   Vigneault, Eric ^a   Kurhanewicz, John ^a   Verhey, Lynn ^a   Roach, Mack ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intensity modulation; Magnetic resonance spectroscopy; Prostate cancer; Segmental irradiation; Three dimensional conformal radiotherapy

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HISTOGRAM; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; RADIOTHERAPY; THREE DIMENSIONAL IMAGING;

HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHYSICS; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032980110     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00502-1     Document Type: Article

References (22)

1. Zietman A.L., Coen J.J., Dallow K.C., Shipley W.U. The treatment of prostate cancer by conventional radiation therapy An analysis of long-term outcome . Int J Radiat Oncol Biol Phys. 32:(2):1995;287-292.
2. Hanks G.E., Buzydlowski J.W., Perez C.A., et al. The ten year outcome of pathologic and imaging node positive patients treated with irradiation in Radiation Therapy Oncology Group (RTOG)-7506. J Urol. 155:(Supplement):1996;611A.
3. Bagshaw M. Linear accelerator radiotherapy of prostate cancer. Fortner J., Sharp P. Accomplishments in cancer research. 1997;116-132 Lippincott-Raven, Philadelphia, New York.
4. Ten Haken R.K., Perez-Tamayo C., Tesser R.J., McShan D.L., Fraass B.A., Lichter A.S. Boost treatment of the prostate using shaped, fixed fields. Int J Radiat Oncol Biol Phys. 16:1989;193-200.
5. Ten Haken R.K., Forman J.D., Heimburger D.K., et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys. 20:1991;1317-1324.
6. Roach M., Pickett B., Holland J., Kapotowski K.A., Marsh D.L., Tatera B.S. The role of the urethragram during simulation for localized prostate cancer. Int J Radiat Oncol Biol Phys. 25:1993;299-307.
7. Roach M., Pickett B., Rosenthal S., Verhey L., Phillips T.L. Defining treatment margins for 3-D based six field conformal (SFC) irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys. 28:1994;267-275.
8. Kurhanewicz J., Dahiya R., Macdonald J.M., Chang L.-H., Thomas T.L., Narayan P. Citrate alterations in primary and metastatic human prostatic adenocarcinomas 1H magnetic resonance spectroscopy and biochemical study . Magn Reson Med. 29:1993;149-157.
9. 3) spatial resolution. Radiology. 198:1996;795-805.
10. Scheidler J, Hricak H, Kurhanewicz J, Yu K, Carroll P, Vigneron D. Combined MR imaging and H1 spectroscopic imaging in prostate cancer localization: Correlation with step section pathology. RSNA. Chicago, IL, 1997.
11. Rosenthal S.A., Roach M. III, Goldsmith B.J., et al. Immobilization improves the reproducibility of patient positioning during six-field conformal radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 29:1993;921-926.
12. Pickett B., Roach M., Verhey L., et al. The value of non-uniform margins for six-field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys. 32:1995;211-218.
13. Roach M., Faillace-Akazawa P., Malfatti C., Holland J., Hricak H. Prostate volumes defined by magnetic resonace imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 35:(5):1996;1011-1018.
14. Roach M., Faillace-Akazawa P., Malfatti C. Prostate volumes and organ movement defined by serial CT scans during 3D conformal radiotherapy. Radiation Oncology Investigations. 5:1997;10.
15. Vigneault E., Pouliot J., Laverdiere J., Roy J., Dorion M. Electronic portal imaging device detection of radioopaque markers for evaluation of prostate position during megavoltage irradiation A clnical study . Int J Radiat Oncol Biol Phys. 37:1997;205-212.
16. Roach M., Pickett B., Weil M., Verhey L. The "critical volume tolerance method" for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 35:1996;1019-1025.
17. Byar D.P., Mostofi F.K. Carcinoma of the prostate Prognostic evaluation of certain pathologic features in 208 radical prostatectomies . Pathol Prostatic Cancer. 29:1972;5-13.
18. McNeal J.E., Price H.M., Redwine E.A., Freiha F.S., Stamey T.A. Stage A versus stage B adenocarcinoma of the prostate Morphological comparison and biological significance . J Urol. 139:1988;61-65.
19. Xia P., Pickett B., Vigneault E., Verhey L., Roach M. Comparison of intensity modulated treatment plans for multiple dominant intra-prostatic lesions of prostate cancer. Int J Radiat Oncol Biol Phy. 42:(Suppl.):1998;208.
20. Mohan R., Zelefsky M., Yang J., et al. The potential of optimization intensity modulation to escalation prostate cancer to 86.4 Gy. Int J Radiat Oncol Biol Phys. 36:(Suppl.):1996;197.
21. Hartmann-Siantar C.L., Cox L.J., von Wittenau A.S. Application of Peregrine Monte Carlo Dose Calculation System to Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys. 39:1997;182-190.
22. Roach M, Hartmann-Siantar C, Moses E; et al. Improving the accuracy of radiation therapy for prostate cancer. Cap Cure Fifth Annual Scientific Retreat, 9/98, Volume 2, CD ROM.